HOOKIPA PHARMA INC's ticker is HOOK and the CUSIP is 43906K100. A total of 55 filers reported holding HOOKIPA PHARMA INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $4 | -42.9% | 8,003 | -6.3% | 0.00% | – |
Q2 2023 | $7 | -99.8% | 8,542 | +153.3% | 0.00% | – |
Q3 2022 | $4,000 | -50.0% | 3,372 | -32.0% | 0.00% | – |
Q2 2022 | $8,000 | -83.3% | 4,962 | -76.6% | 0.00% | – |
Q1 2022 | $48,000 | -37.7% | 21,229 | +154.4% | 0.00% | – |
Q3 2021 | $77,000 | +2.7% | 8,345 | +1.2% | 0.00% | – |
Q2 2021 | $75,000 | +7400.0% | 8,245 | +6496.0% | 0.00% | – |
Q4 2020 | $1,000 | -75.0% | 125 | -74.3% | 0.00% | – |
Q3 2020 | $4,000 | – | 486 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Redmile Group, LLC | 1,842,902 | $17,452,000 | 0.32% |
Samsara BioCapital, LLC | 116,602 | $1,104,000 | 0.31% |
Artal Group S.A. | 599,616 | $5,678,000 | 0.14% |
HHLR ADVISORS, LTD. | 943,254 | $8,933,000 | 0.07% |
DAFNA Capital Management LLC | 22,061 | $209,000 | 0.07% |
Baker Brothers Advisors | 700,481 | $6,634,000 | 0.03% |
ZACKS INVESTMENT MANAGEMENT | 72,064 | $682,000 | 0.01% |
HOWLAND CAPITAL MANAGEMENT LLC | 14,728 | $139,000 | 0.01% |
ETF MANAGERS GROUP, LLC | 14,374 | $139,000 | 0.00% |
Squarepoint Ops LLC | 12,699 | $120,000 | 0.00% |